Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Paul Johnson visited Mexico City last month (25-27 October) to be part of the official launch of the TRANSDIA project – a UK-Mexico collaboration to tackle type 1 diabetes.

The international collaboration aims to establish a clinical-grade human islet isolation facility as a precursor to delivering an islet transplant programme in Mexico to treat patients with type 1 diabetes. In addition, the collaboration involves an innovative pre-clinical research project to evaluate the role of gene therapy in improving transplant outcomes, with the ultimate aim of enabling islet transplantation in children.

TRANSDIA involves collaboration between the Centre for Molecular and Cell-based Therapeutics (CMCBT) and three medical institutions that are members of the NIH Organ Donor Network in Mexico City, Oxford Expression Technologies Ltd, Oxford Brookes University and the Nuffield Department of Surgical Sciences (NDS), University of Oxford, who are leading on the islet transplant side of the project.  

It is funded through the Newton Fund – UK-Mexico Collaborative Industrial R&D Program. In the UK, funding has been provided by Innovate UK and in Mexico funding has been provided by CONACYT (the Mexican Council for Science and Technology). 

It is estimated that there are more than 35 million patients with type 1 diabetes worldwide. This form of diabetes usually has its onset in children and adolescents and since the 1980s, Mexico has witnessed a year on year increase in the incidence of type 1 diabetes such that it is now the most frequent metabolic disorder affecting children and young adults. 

The disorder is caused by auto-immune destruction of the insulin-producing beta cells within the pancreatic islets of Langerhans. Pancreatic islet transplantation is a minimally-invasive treatment that can replace beta cells, thereby normalising glucose levels and reversing the life-threatening complication of hypoglycaemia unawareness (dangerously low blood sugar levels without warning signs). Over 50 per cent of patients undergoing this treatment no longer require insulin injections. Currently, Mexico does not have an islet transplant programme.

Professor Johnson, who is Director of DRWF Islet Isolation Facility and the Lead for the Oxford Islet Transplant Programme at NDS, visited Mexico City to speak at a symposium to launch the international collaboration, meet with partners and visit local hospitals.

Professor Robert Possee, CEO of Oxford Expression Technologies Ltd, is the lead for the UK-Oxford partners and Professor Linda King, Oxford Brookes’ Pro Vice-Chancellor for Research and Global Partnerships, is the lead for the project at Oxford Brookes.

Oxford Expression Technologies (OET) is a spin out company launched jointly by Oxford Brookes University and the Natural Environment Research Council (NERC) in 2007.

Dr Juan J. Plata-Muñoz, Medical Director of CMCBT, is the lead for the Mexican partners. CMCBT is a biotech company founded by researchers of the Tecnologico de Monterrey, Mexico City in 2013 and launched as a spin out company in 2015.

Similar stories

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Omair Shariq wins Best Clinical Paper at the American Association of Endocrine Surgeons 2021 Annual Meeting

Dr Omair Shariq, a DPhil student and clinical research fellow in the Nuffield Department of Surgical Sciences (NDS) and Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), has received the 2021 Best Presentation for Clinical Research award during the 41st Annual Meeting of the American Association of Endocrine Surgeons (AAES), which was held virtually on 25-27 April 2021.

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Government boost for digitisation and AI in pathology services

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.

QUOD enters partnership with Evotec

Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.

How Oxford Medical Sciences is fighting Coronavirus

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic.

Blog posts

Wrap up of 2021

After a brilliant year of hard work and dedication, the SITU team has done some reflection on 2021, focusing on key events, trial progression, and more. Read on to discover how the year 2021 went for the SITU team...

Celebrating Anti-Bullying Week with words of kindness

Keeva Heap, who is undertaking a communications work experience placement at the Nuffield Department of Surgical Sciences (NDS), shares our words of kindness In honour of Anti-Bullying Week.

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.